DAX 25.118 +0,9%ESt50 6.284 +1,3%MSCI World 4.851 +0,8%Top 10 Crypto 8,26 +0,9%Nas 26.207 +1,3%Bitcoin 55.767 +0,8%Euro 1,1439 +0,1%Öl 76,1 +0,3%Gold 4.111 -0,3%
Beliebte Suche
DAX 40ÖlpreisEuro - DollarBitcoin - EuroGoldpreis
Meistgesucht
BioNTech (ADRs)A2PSR2TeslaA1CX3TAmazon906866NEL ASAA0B733Microsoft870747Apple865985Siemens EnergyENER6YBASFBASF11NVIDIA918422Lufthansa823212Mercedes-Benz Group (ex Daimler)710000BayerBAY001Daimler TruckDTR0CKPlug PowerA1JA81TUITUAG00
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero.Hier informieren
Top News
Suche...
Jetzt kostenlos
bei finanzen.net anmelden
Watchlists & MusterdepotsTools & integriertes TradingNewsletter, Trading-Desk uvm.
Schon einen Account? Anmelden

EQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

Werte in diesem Artikel
Aktien
SCHOTT Pharma
20.05 EUR -0.15 EUR -0.74 %
Charts | News | Analysen
Aktie kaufen

EQS Preliminary announcement financial reports: SCHOTT Pharma AG & Co. KGaA / Preliminary announcement on the disclosure of financial statements
SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

11.11.2024 / 16:00 CET/CEST
Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Werbung

SCHOTT Pharma AG & Co. KGaA hereby announces that the following financial reports shall be disclosed:

Report Type: Quarterly/ Interim statement within the 1st half-year

Language: German
Date of disclosure: February 13, 2025
Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/

Language: English
Date of disclosure: February 13, 2025
Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/

Report Type: Quarterly/ Interim statement within the 2nd half-year

Language: German
Date of disclosure: August 12, 2025
Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/

Language: English
Date of disclosure: August 12, 2025
Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/

11.11.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: SCHOTT Pharma AG & Co. KGaA
Hattenbergstraße 10
55122 Mainz
Germany

 
End of News EQS News Service
Werbung

2027201  11.11.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2027201&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Aktuelle SCHOTT Pharma Aktie News

Werbung

SCHOTT Pharma Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für SCHOTT Pharma nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
08:41 SCHOTT Pharma Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
09.07.26 SCHOTT Pharma Kaufen DZ BANK
09.07.26 SCHOTT Pharma Buy Deutsche Bank AG
09.07.26 SCHOTT Pharma Hold Jefferies & Company Inc.
09.07.26 SCHOTT Pharma Outperform RBC Capital Markets